[1]陈　颖,王伟佳,胡　婷,等.急性胰腺炎患者血清C1q补体水平与疾病严重程度的相关性研究[J].现代检验医学杂志,2021,36(04):45-50.[doi:10.3969/j.issn.1671-7414.2021.04.010]
　CHEN Ying,WANG Wei-jia,HU Ting,et al.Research on Relevant Serum C1q Complement Level inthe Severity of Acute Pancreatitis[J].Journal of Modern Laboratory Medicine,2021,36(04):45-50.[doi:10.3969/j.issn.1671-7414.2021.04.010]
点击复制

急性胰腺炎患者血清C1q补体水平与疾病严重程度的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年04期
页码:
45-50
栏目:
论　著
出版日期:
2021-07-31

文章信息/Info

Title:
Research on Relevant Serum C1q Complement Level inthe Severity of Acute Pancreatitis
文章编号:
1671-7414（2021）04-045-06
作者:
陈　颖; 王伟佳; 胡　婷; 黄福达; 缪丽韶; 唐　凤; 罗楚君
（中山大学附属中山医院检验医学中心，广东中山 528403）
Author(s):
CHEN Ying;  WANG Wei-jia;  HU Ting;  HUANG Fu-da;  MIU Li-shao;  TANG Feng;  LUO Chu-jun
(Department of Laboratory Diagnosis,Zhongshan Hospital Affiliated to Sun Yat-sen University,Guangdong Zhongshan 528403,China）
关键词:
急性胰腺炎; 补体C1q ; 超敏C 反应蛋白
分类号:
R576；R446.62
DOI:
10.3969/j.issn.1671-7414.2021.04.010
文献标志码:
A
摘要:
目的　分析急性胰腺炎（acute pancreatitis，AP) 患者血清补体1q（C1q）水平的变化，探讨C1q 诊断及预测AP 患者严重程度的临床价值。方法　选取2019 年11 月~2020 年10 月中山大学附属中山医院收治AP 患者104 例，分为轻症AP（MAP）47 例、中度重症AP（MSAP）32 例和重症AP（SAP）25 例；对照组选自同期52 例健康体检者。检测各组血清C1q 水平，同时检测三酰甘油（TG）和超敏C 反应蛋白（hs-CRP) 等生化指标，比较各组之间的差异；使用逐步多元线性回归分析各因素对C1q 水平的影响。采用ROC 曲线及曲线下面积（AUC) 探讨C1q 诊断AP 患者及预测严重程度的有效性。结果　AP 患者血清C1q 水平显著低于对照组，差异有统计学意义（t=-8.317，P ＜ 0.05）；与MAP 组和MSAP 组相比，SAP 组血清C1q 水平显著降低，差异均有统计学意义（t=5.624 和4.132，均P ＜ 0.05）；MAP 组和MSAP 组血清C1q 水平相比，差异无统计学意义（t=1.528，P=0.132）。校正了年龄、性别、病史、病因及hs-CRP 等其他生化指标的影响后，AP 患者血清C1q 水平与急性生理学与慢性健康状况评分系统Ⅱ（APACHE Ⅱ评分）（β=-0.587，P ＜ 0.05）与hs-CRP（β=-0.279，P ＜ 0.05）有关。ROC 显示血清C1q 诊断AP 患者的AUC 为0.854，取诊断界限值为 224.40μg/ml 时，敏感度和特异度分别为78.85%，88.46%。血清C1q 诊断SAP 患者时AUC 为0.822，取诊断界限值为203.56μg/ml 时，敏感度为80.00%，特异度为82.28%；APACHE Ⅱ评分诊断SAP 效能优于C1q，差异有统计学意义（Z=2.975，P=0.003)；用二元Logistic 回归求出C1q 和hs-CRP 联合诊断SAP 的预测概率值，AUC 为0.926,敏感度、特异度分别为84.00% 和88.61%，与APACHE Ⅱ评分诊断SAP 相比，二者之间差异无统计学意义（Z=0.582，P=0.560)。结论　AP 患者血清C1q 水平明显降低，可作为AP 及SAP 诊断的潜在指标；C1q 和hs-CRP 联合检测可能是SAP 诊断及预测较好的实验室检测指标。

参考文献/References:

[1] YU Bingjun, LI Jiarong, LI Nianshuang,et al. Progressionto recurrent acute pancreatitis after a first attackof acute pancreatitis in adults[J]. Pancreatology, 2020,20(7): 1340-1346.
[2] 祖瑞铃，叶波．不同肿瘤与并发胰腺炎患者血清AMY 和LPS 的分布水平及实验诊断价值研究[J]．现代检验医学杂志,2019,34(1):76-78, 82.ZU Ruiling, YE Bo. Distributions and diagnostic valuesof serum amylase and lipase in patients with varioustypes of tumors and those with pancreatitis [J]. Journalof Modern Laboratory Medicine, 2019, 34(1): 76-78,82.
[3] PORTELLI M, JONES C D. Severe acute pancreatitis:pathogenesis, diagnosis and surgical management[J].Hepatobiliary & Pancreatic Diseases International,2017, 16(2): 155-159.
[4] FONTEH P, SMITH M, BRAND M. Adaptive immunecell dysregulation and role in acute pancreatitis diseaseprogression and treatment[J]. Archivum ImmunologiaeetTherapiae Experimentalis, 2018, 66(3): 199-209.
[5] HARTWIG W, KLAFS M, KIRSCHFINK M, et al. Interactionof complement and leukocytes in severe acutepancreatitis: potential for therapeutic intervention[J].American Journal of Physiology-Gastrointestinal andLiver Physiology, 2006, 291(5): G844-G850.
[6] ZHANG Lifeng, QIAO Zhenguo, FENG Huang, et al.The early predictive role of complement C3 and C4 inpatients with acute pancreatitis[J]. Journal of ClinicalLaboratory Analysis, 2020, 34(9607):e23205.
[7] CHAUDHARY H, DANIEL R, PILANIA R K, et al.Catastrophes due to missing complements: C1q deficiencylupus with Kikuchi-Fujimoto disease and macrophageactivation syndrome[J]. Rheumatology (Oxford,England), 2020, 59(7): 1778-1780.
[8] 赵娟, 毛达勇. 糖尿病血管病变患者血清补体C1q和B 因子检测的临床意义[J]．现代检验医学杂志，2018, 33(4):98-99, 103.ZHAO Juan, MAO Dayong. Clinical significance of detectingserum complement C1q and factor B in patientswith type 2 diabetic vascular disease [J]. Journal ofModern Laboratory Medicine, 2018, 33(4): 98-99,103.
[9] 中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编辑委员会, 《中华消化杂志》编辑委员会. 中国急性胰腺炎诊治指南（2019 年，沈阳）[J].中华胰腺病杂志, 2019, 19(5): 321-331.Pancreatic Disease Group, Digestive Disease Brunch,Chinese Medical Association, Editorial Board for ChineseJournal of Pancreatology, Editorial Board forChinese Journal of Digestion. Guideline for the diagnosisand treatment of acute pancreatitis in China （2019shenyang）[J]. Chin J Pancreatol, 2019,19(5): 321-331.
[10] FORSMARK C E, VEGE S S, WILCOX C M. Acutepancreatitis[J]. The New England Journal of Medicine,2016, 375(20): 1972-1981.
[11] BRUBAKER L, LUU S, HOFFMAN K, et al. Microbiomechanges associated with acute and chronic pancreatitis:A systematic review[J]. Pancreatology ,2021,21(1): 1-14.
[12] GRAY R,CAGLIANI J,AMODU L I, et al. Maximizingthe use of scoring systems in the prediction of outcomesin acute pancreatitis[J]. Digestion, 2019, 99(2): 166-171.
[13] 陈方莹, 柏小寅, 吴东. 预测急性胰腺炎严重程度的评分系统及生物标志物[J]. 中华内科杂志,2019,58(8): 615-619.CHEN Fangying, BAI Xiaoyin, WU Dong. The severityscoring system and prognostic biological markers ofacute pancreatitis [J]. Chin J Intern Med, 2019,58(8):615-619.
[14] STAUBLI S M, OERTLI D, NEBIKER C A. Laboratorymarkers predicting severity of acute pancreatitis[J].Critical Reviews in Clinical Laboratory Sciences, 2015,52(6): 273-283.
[15] LIANG Yi , ZHAO Xianwei , MENG Fanliang. Procalcitonin,C-reactive protein, and neutrophil ratio contributeto the diagnosis and prognosis of severe acutepancreatitis[J]. Iranian Journal of Public Health, 2019,48(12) : 2177-2186.
[16] VACCA G, REGINELLI A, URRARO F, et al. Mag-netic resonance severity index assessed by T1-weightedimaging for acute pancreatitis: correlation with clinicaloutcomes and grading of the revised Atlanta classification-a narrative review[J]. Gland surgery, 2020, 9(6):2312-2320.
[17] IMAM Z, HANNA A, JOMAA D, et al. Hypercalcemiaof malignancy and acute pancreatitis[J]. Pancreas,2021, 50(2): 206-213.
[18] MATHURAM T U, PONNUSWAMY A, THOMAS R.Predictivity of biochemical markers on aetiology andlength of hospitalisation in acute pancreatitis[J]. Cureus,2020, 12(12): e11989.

相似文献/References:

[1]高其亮a,毛星荐b,吴 钢a.急性胰腺炎患者血清miR-455-3p，miR-141-3p 水平表达与病情严重程度的关系研究[J].现代检验医学杂志,2024,39(05):41.[doi:10.3969/j.issn.1671-7414.2024.05.008]
　GAO Qilianga,MAO Xingjianb,WU Ganga.Study on the Relationship between the Expression of Serum miR-455-3p and miR-141-3p Levels and the Severity of Disease in Patients with Acute Pancreatitis[J].Journal of Modern Laboratory Medicine,2024,39(04):41.[doi:10.3969/j.issn.1671-7414.2024.05.008]

备注/Memo

备注/Memo:
基金项目：中山市医学科研基金项目(2016J008)。
作者简介：陈颖（1983-），女，硕士, 主管技师，研究方向：临床检验诊断学，E-mail：chenying2007@163.com。通信作者：王伟佳（1981-），男，博士，主任技师，硕士研究生导师, E-mail：wwj0760@163.com。
更新日期/Last Update: 1900-01-01